This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in C19_div01_subXX |
PMC3753099 1. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. | *19593099* 19593099 | ||
2. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. | *19429813* 19429813 | ||
3. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol 2008; 294 (3): H1103-18 | *18192217* 18192217 | ||
4. Aldosteronism: an immunostimulatory state precedes proinflammatory/fibrogenic cardiac phenotype. | *12860567* 12860567 | ||
5. Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. | *11762939* 11762939 | ||
6. Inflammatory response following acute magnesium deficiency in the rat. | *10838183* 10838183 | ||
7. Management of life-threatening autonomic hyper-reflexia using magnesium sulphate in a patient with a high spinal cord injury in the intensive care unit. | *11990279* 11990279 | ||
PMC2896314 8. Aldosteronism and peripheral blood mononuclear cell activation: a neuroendocrine-immune interface. | *14576195* 14576195 | ||
PMC1065104 9. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study. | *15693962* 15693962 | ||
10. Hypomagnesaemia in chronic, stable asthmatics: prevalence, correlation with severity and hospitalization. | *11028655* 11028655 | ||
11. Reduced intracellular magnesium concentrations in asthmatic patients. | *10836320* 10836320 | ||
12. Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure. | *16177005* 16177005 | ||
13. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. | *10620073* 10620073 | ||
14. Enhanced production of IL-1beta and IL-6 following endotoxin challenge in rats with dietary magnesium deficiency. | *11346186* 11346186 | ||
15. Magnesium depletion with hypo- or hyper- function of the biological clock may be involved in chronopathological forms of asthma. | *15945613* 15945613 | ||
16. Changes in gene expression in the lungs of Mg-deficient mice are related to an inflammatory process. | *15726901* 15726901 | ||
17. Enhanced release of IL-1beta and TNF-alpha following endotoxin challenge from rat alveolar macrophages cultured in low-mg(2+) medium. | *12892381* 12892381 | ||
18. Urinary magnesium excretion in asthmatic children receiving magnesium supplementation: a randomized, placebo-controlled, double-blind study. | *14979636* 14979636 | ||
PMC1345685 19. Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages. | *16251362* 16251362 | ||
PMC1266035 20. Immunolocalization of RANKL is increased and OPG decreased during dietary magnesium deficiency in the rat. | *16162295* 16162295 | ||
21. Diet and asthma. | *11059944* 11059944 | ||
PMC59508 22. Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? | *11686892* 11686892 | ||
PMC1745426 23. Dietary antioxidants and magnesium in type 1 brittle asthma: a case control study. | *10325914* 10325914 | ||
24. Apoptotic change in response to magnesium therapy after moderate diffuse axonal injury in rats. | *15515203* 15515203 | ||
25. Dietary micronutrients/antioxidants and their relationship with bronchial asthma severity. | *11167351* 11167351 | ||
26. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. | *10426331* 10426331 | ||
27. Hypomagnesemia in acute and chronic care patient populations. | *1595603* 1595603 | ||
28. Intravenous magnesium sulfate treatment in a child with status asthmaticus. | *10365726* 10365726 | ||
29. Expression of the nuclear factor-kappaB and proto-oncogenes c-fos and c-jun are induced by low extracellular Mg2+ in aortic and cerebral vascular smooth muscle cells: possible links to hypertension, atherogenesis, and stroke. | *12944025* 12944025 | ||
30. Serum magnesium levels and acute exacerbation of chronic obstructive pulmonary disease: a retrospective study. | *16254259* 16254259 | ||
31. Sufficient dosing of intravenous magnesium for severe asthma. | *11326199* 11326199 | ||
32. Management of acute, severe asthma in children. | *12086560* 12086560 | ||
33. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease (COPD). | *11977322* 11977322 | ||
34. Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. | *16564020* 16564020 | ||
35. Serum magnesium levels in asthmatic children during and between exacerbations. | *11177094* 11177094 | ||
36. Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. | *11348887* 11348887 | ||
37. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. | *14989640* 14989640 | ||
38. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat. | *15923157* 15923157 | ||
39. Accelerated thymus involution in magnesium-deficient rats is related to enhanced apoptosis and sensitivity to oxidative stress. | *10615213* 10615213 | ||
40. The thymus: a barometer of malnutrition. | *10615206* 10615206 | ||
41. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. | *12419529* 12419529 | ||
42. Expression of Bax and Bcl-2 proteins during hypoxia in cerebral cortical neuronal nuclei of newborn piglets: effect of administration of magnesium sulfate. | *11368946* 11368946 | ||
43. Pathophysiology of perinatal brain damage. | *10525170* 10525170 | ||
44. Magnesium deficiency: effect on bone and mineral metabolism in the mouse. | *12370796* 12370796 | ||
45. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. | *12944451* 12944451 | ||
46. Ceramide and sphingomyelinases in the regulation of stress responses. | *11001568* 11001568 | ||
47. Reduced intracellular Mg concentrations in patients with acute asthma. | *12527611* 12527611 | ||
48. Electrolyte disturbances in patients with chronic, stable asthma: effect of therapy. | *11502640* 11502640 | ||
49. Effects of magnesium sulfate on neuron apoptosis and expression of caspase-3, bax and bcl-2 after cerebral ischemia-reperfusion injury. | *14570617* 14570617 | ||
50. [Magnesium and inflammation: lessons from animal models]. | *15692164* 15692164 | ||
51. The role of magnesium in traumatic brain injury. | *15577090* 15577090 | ||
52. Magnesium concentration in plasma, leukocytes and urine of children with intermittent asthma. | *11580927* 11580927 | ||
53. Magnesium. An update on physiological, clinical and analytical aspects. | *10727669* 10727669 | ||
54. Evaluation of magnesium in serum and urine in patients with pulmonary diseases. | *16329623* 16329623 | ||
55. Magnesium regulates hypoxia-stimulated apoptosis in the human placenta. | *10731470* 10731470 | ||
56. Corneal changes in magnesium-deficient rats. | *12827051* 12827051 | ||
57. Hypomagnesemic disorders. | *11219227* 11219227 | ||
58. Development of ionized hypomagnesemia is associated with higher mortality rates. | *12682476* 12682476 | ||
59. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density. | *15860239* 15860239 | ||
60. Plasma magnesium in adult asthmatics at the Lagos University Teaching Hospital, Nigeria. | *14640172* 14640172 | ||
61. Diet and obstructive lung diseases. | *12192737* 12192737 | ||
62. The critical role of magnesium ions in osteoclast-matrix interaction: implications for divalent cations in the study of osteoclastic adhesion molecules and bone resorption. | *1459174* 1459174 | ||
63. Possible roles of magnesium on the immune system. | *14506478* 14506478 | ||
64. Retinal changes in magnesium-deficient rats. | *11133179* 11133179 | ||
65. Magnesium and microvascular endothelial cells: a role in inflammation and angiogenesis. | *15769616* 15769616 | ||
66. Magnesium in cell proliferation and differentiation. | *10430554* 10430554 | ||
67. Organ dysfunction following hemorrhage and sepsis: mechanisms and therapeutic approaches (Review). | *10567665* 10567665 | ||
68. Amiloride increases neuronal damage after traumatic brain injury in rats. | *15466959* 15466959 | ||
69. Comparison of mechanism and functional effects of magnesium and statin pharmaceuticals. | *15466951* 15466951 | ||
70. Hypomagnesemia due to beta 2-agonist use in bronchial asthma. | *1484002* 1484002 | ||
71. Assessment of magnesium status in patients with bronchial asthma. | *11011755* 11011755 | ||
72. Metabolic effects of beta 2-agonists. | *1353501* 1353501 | ||
73. An investigation of hypomagnesemia among ambulatory urban African Americans. | *10496643* 10496643 | ||
74. Magnesium deficiency in critical illness. | *15665255* 15665255 | ||
75. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats. | *15165363* 15165363 | ||
76. Bone loss induced by dietary magnesium reduction to 10% of the nutrient requirement in rats is associated with increased release of substance P and tumor necrosis factor-alpha. | *14704297* 14704297 | ||
77. Magnesium deficiency induces apoptosis in primary cultures of rat hepatocytes. | *12888628* 12888628 | ||
78. N-methyl-D-aspartate receptor blockade inhibits cardiac inflammation in the Mg2+-deficient rat. | *15169828* 15169828 | ||
79. Perinatal brain damage: underlying mechanisms and neuroprotective strategies. | *12445595* 12445595 | ||
80. Effect of long-term, postasphyxial administration of magnesium sulfate on immunostaining of microtubule-associated protein-2 and activated caspase-3 in 7-day-old rat brain. | *12113878* 12113878 | ||
81. Concentrations of copper, zinc and various elements in serum of patients with bronchial asthma. | *10941719* 10941719 | ||
82. Magnesium-deficient medium enhances NO production in alveolar macrophages isolated from rats. | *12570925* 12570925 | ||
83. Stress protein expression cDNA array study supports activation of neutrophils during acute magnesium deficiency in rats. | *12030422* 12030422 | ||
84. Mechanisms underlying the enhanced elevation of IL-1beta and TNF-alpha mRNA levels following endotoxin challenge in rat alveolar macrophages cultured with low-Mg2+ medium. | *12635866* 12635866 | ||
85. Effects of a low extracellular magnesium concentration and endotoxin on IL-1beta and TNF-alpha release from, and mRNA levels in, isolated rat alveolar macrophages. | *12635865* 12635865 | ||
86. Low extracellular Mg2+ concentrations suppress phagocytosis in vitro by alveolar macrophages from rats. | *10761186* 10761186 | ||
87. Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients. | *11153897* 11153897 | ||
88. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption. | *10612083* 10612083 | ||
89. The evaluation and management of acute, severe asthma. | *12428545* 12428545 | ||
90. Cell physiology of magnesium. | *12537986* 12537986 | ||
91. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. | *16180088* 16180088 | ||
92. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. | *1584207* 1584207 | ||
93. Role of magnesium in genomic stability. | *11295157* 11295157 | ||
94. Function and pharmacology of TRPM cation channels. | *15843919* 15843919 | ||
95. Effects of magnesium sulfate administration during hypoxia on Ca(2+) influx and IP(3) receptor modification in cerebral cortical neuronal nuclei of newborn piglets. | *16474998* 16474998 | ||
96. Low extracellular magnesium ions induce lipid peroxidation and activation of nuclear factor-kappa B in canine cerebral vascular smooth muscle: possible relation to traumatic brain injury and strokes. | *12697280* 12697280 | ||
97. Physiologic concentrations of magnesium and placental apoptosis: prevention by antioxidants. | *11506852* 11506852 | ||
98. Reduction of dietary magnesium by only 50% in the rat disrupts bone and mineral metabolism. | *16601920* 16601920 | ||
99. Nitric oxide further attenuates pulmonary hypertension in magnesium-treated piglets. | *12421268* 12421268 | ||
100. Genetics of hereditary disorders of magnesium homeostasis. | *14634861* 14634861 | ||
101. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports. | *12837909* 12837909 | ||
102. Pharmacologic therapy of persistent pulmonary hypertension of the newborn. | *11316514* 11316514 | ||
103. Ionized magnesium levels and the ratio of ionized calcium to magnesium in asthma patients before and after treatment with magnesium. | *16319040* 16319040 | ||
104. Sphingomyelinases in cell regulation. | *10024495* 10024495 | ||
105. Impairment of the ryanodine-sensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis. | *11442313* 11442313 | ||
106. Calcium uptake by sarcoplasmic reticulum is impaired during the hypodynamic phase of sepsis in the rat heart. | *11198357* 11198357 | ||
107. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. | *16256834* 16256834 | ||
108. Lethal iatrogenic hypermagnesemia. | *12174756* 12174756 | ||
109. Activation of transcription factors AP-1 and NF-kappaB in chronic cyclosporine A nephrotoxicity: role in beneficial effects of magnesium supplementation. | *12698095* 12698095 | ||
110. Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. | *12364856* 12364856 | ||
111. Limitation of apoptotic changes in renal tubular cell injury induced by hyperoxaluria. | *15249986* 15249986 | ||
112. Biochemical changes induced by hypomagnesaemia in lactating cows and ewes. | *11890174* 11890174 | ||
113. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-kappaB, and de novo ceramide. | *21984552* 21984552 | ||
114. Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. | *24944268* 24944268 | ||
PMC2801335 115. Regulation of the mitochondrial permeability transition in kidney proximal tubules and its alteration during hypoxia-reoxygenation. | *19741014* 19741014 | ||
PMC3264499 116. Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis. | *22208725* 22208725 | ||
PMC3671580 117. Cardioplegia and diazoxide modulate STAT3 activation and DNA binding. | *17888982* 17888982 | ||
PMC4822408 118. Ion channels in innate and adaptive immunity. | *25861976* 25861976 | ||
119. Cadmium-induced cytosolic Ca2+ elevation and subsequent apoptosis in renal tubular cells. | *19413654* 19413654 | ||
PMC3511825 120. A key role for Mg(2+) in TRPM7's control of ROS levels during cell stress. | *22587440* 22587440 | ||
121. Magnesium deficiency promotes a pro-atherogenic phenotype in cultured human endothelial cells via activation of NFkB. | *20600865* 20600865 | ||
PMC4578555 122. Comparison of the reaction of bone-derived cells to enhanced MgCl2-salt concentrations. | *25482335* 25482335 | ||
PMC3134422 123. Microcirculatory changes during open label magnesium sulphate infusion in patients with severe sepsis and septic shock. | *21672227* 21672227 | ||
124. L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. | *19933511* 19933511 | ||
125. Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury. | *20401440* 20401440 | ||
PMC3032522 126. Magnesium induces neuronal apoptosis by suppressing excitability. | *21364668* 21364668 | ||
127. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J 2011; 75 (2): 237-45 | *21150127* 21150127 | ||
PMC1855626 128. Magnesium metabolism and its disorders. | *18568054* 18568054 | ||
129. Nuclear factor-kappaB modulation in patients undergoing induction chemotherapy for acute myelogenous leukemia. | *19010875* 19010875 | ||
PMC3532932 130. Management of mineral and bone disorder after kidney transplantation. | *22614626* 22614626 | ||
PMC3556002 131. The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: One step forward in dosing. | *23351890* 23351890 | ||
PMC3043756 132. Fluid and electrolyte disturbances in critically ill patients. | *21468200* 21468200 | ||
133. Therapeutic effect of magnesium sulphate on carbon monoxide toxicity-mediated brain lipid peroxidation. | *23436663* 23436663 | ||
PMC3227031 134. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? | *22140321* 22140321 | ||
135. Low magnesium concentration in erythrocytes of children with acute asthma. | *17237571* 17237571 | ||
PMC3533145 136. Magnesium concentration in acute asthmatic children. | *23429727* 23429727 | ||
PMC2707206 137. Magnesium deficiency causes loss of response to intermittent hypoxia in paraganglion cells. | *19433582* 19433582 | ||
PMC2958049 138. Mechanisms of TNFalpha-induced cardiac dysfunction in cholestatic bile duct-ligated mice: interaction between TNFalpha and endocannabinoids. | *20626112* 20626112 | ||
PMC3884513 139. Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. | *22611240* 22611240 | ||
PMC3218197 140. Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. | *21932365* 21932365 | ||
PMC3195797 141. Idiopathic severe hypermagnesemia in an extremely low birth weight infant on the first day of life. | *22025925* 22025925 | ||
142. Magnesium supplement promotes sciatic nerve regeneration and down-regulates inflammatory response. | *21609904* 21609904 | ||
143. The biochemical function of Mg(2)+ in insulin secretion, insulin signal transduction and insulin resistance. | *20228013* 20228013 | ||
144. Phagocyte priming by low magnesium status: input to the enhanced inflammatory and oxidative stress responses. | *20228008* 20228008 | ||
145. Magnesium deficiency and metabolic syndrome: stress and inflammation may reflect calcium activation. | *20513641* 20513641 | ||
146. Vascular biology of magnesium and its transporters in hypertension. | *21199786* 21199786 | ||
147. Magnesium homeostasis and aging. | *20228001* 20228001 | ||
148. Effects of long-term dietary intake of magnesium on oxidative stress, apoptosis and ageing in rat liver. | *18705541* 18705541 | ||
149. Magnesium homeostasis and alcohol consumption. | *19271417* 19271417 | ||
150. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. | *17972464* 17972464 | ||
151. Influence of graded magnesium deficiencies on white blood cell counts and lymphocyte subpopulations in rats. | *16955720* 16955720 | ||
152. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. | *17402291* 17402291 | ||
PMC3087884 153. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. | *19204407* 19204407 | ||
PMC3275783 154. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. | *21750166* 21750166 | ||
155. Intra-articular magnesium sulfate (MgSO4) reduces experimental osteoarthritis and nociception: association with attenuation of N-methyl-D-aspartate (NMDA) receptor subunit 1 phosphorylation and apoptosis in rat chondrocytes. | *19490963* 19490963 | ||
PMC53579 156. Magnesium dietary intake modulates blood lipid levels and atherogenesis. | *2308944* 2308944 | ||
157. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. | *18396393* 18396393 | ||
PMC4507414 158. Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. | *21900205* 21900205 | ||
PMC2735421 159. Differential binding of inorganic particles to MARCO. | *18836211* 18836211 | ||
160. Combined treatment with progesterone and magnesium sulfate positively affects traumatic brain injury in immature rats. | *23546895* 23546895 | ||
161. An under-recognized complication of treatment of acute severe asthma. | *18410827* 18410827 | ||
162. The syndrome of alcoholic ketoacidosis. | *1867237* 1867237 | ||
163. Cisplatin nephrotoxicity: a review. | *17700201* 17700201 | ||
164. Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. | *21272846* 21272846 | ||
165. Magnesium sulfate increases intracellular magnesium reducing inflammatory cytokine release in neonates. | *23590581* 23590581 | ||
166. Prevention of thiazide-induced hypokalemia without magnesium depletion by potassium-magnesium-citrate. | *16645424* 16645424 | ||
167. Magnesium sulfate-induced nonallergic anaphylaxis. | *17378266* 17378266 | ||
168. Granulocyte-macrophage colony-stimulating factor (GM-CSF), hypocalcemia, and hypomagnesemia. | *2185678* 2185678 | ||
169. Magnesium and the inflammatory response: potential physiopathological implications. | *16712775* 16712775 | ||
170. Effects of supplementation with higher levels of manganese and magnesium on immune function. | *17679553* 17679553 | ||
171. Effect of Zn and Mg in tricalcium phosphate and in culture medium on apoptosis and actin ring formation of mature osteoclasts. | *18824780* 18824780 | ||
172. Neuroprotective gene profile in the brain of magnesium-deficient mice. | *18400454* 18400454 | ||
173. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. | *21111716* 21111716 | ||
174. Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. | *21040713* 21040713 | ||
175. Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats. | *20811796* 20811796 | ||
176. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice. | *23125223* 23125223 | ||
177. Role of ERK signaling in the neuroprotective efficacy of magnesium sulfate treatment during focal cerebral ischemia in the gerbil cortex. | *21793341* 21793341 | ||
178. Role of PI3K/Akt signaling in the protective effect of magnesium sulfate against ischemia-perfusion injury of small intestine in rats. | *20819605* 20819605 | ||
179. Observations on serum iron, zinc, copper and magnesium in intravenously fed patients with chronic sepsis. | *16831761* 16831761 | ||
180. Alterations in trace element and plasma amino-acid profile in experimental gram-negative septicaemia. | *16831722* 16831722 | ||
181. Magnesium and its transporters in cancer: a novel paradigm in tumour development. | *22671428* 22671428 | ||
182. Endothelial cells and magnesium: implications in atherosclerosis. | *22248353* 22248353 | ||
183. Cell (patho)physiology of magnesium. | *18047467* 18047467 | ||
184. COPD: magnesium in the plasma and polymorphonuclear cells of patients during a stable phase. | *17364676* 17364676 | ||
185. Magnesium-adenosine triphosphate in the treatment of shock, ischemia, and sepsis. | *1737460* 1737460 | ||
186. Using small molecule GSK3beta inhibitors to treat inflammation. | *20858169* 20858169 | ||
187. Oral magnesium supplementation in asthmatic children: a double-blind randomized placebo-controlled trial. | *16788707* 16788707 | ||
188. Protective effects of magnesium supplementation on metabolic energy derangements in lipopolysaccharide-induced cardiotoxicity in mice. | *22939974* 22939974 | ||
189. Decreased renal mRNA expression of TRPM6 is associated with hypomagnesemia in C57BL/6 asthmatic mice. | *21284342* 21284342 | ||
190. TNFalpha receptor knockout in mice reduces adverse effects of magnesium deficiency on bone. | *19919525* 19919525 | ||
191. Effect of dolomite on the repair of bone defects in rats: histological study. | *20886435* 20886435 | ||
192. Vitamin K2, a gamma-carboxylating factor of gla-proteins, normalizes the bone crystal nucleation impaired by Mg-insufficiency. | *18785118* 18785118 | ||
193. Modulation of lung-associated natural killer activity by resident and activated alveolar macrophages. | *2338360* 2338360 | ||
194. Chlorophyll revisited: anti-inflammatory activities of chlorophyll a and inhibition of expression of TNF-alpha gene by the same. | *22038065* 22038065 | ||
195. Dietary calcium supplementation suppresses bone formation in magnesium-deficient rats. | *17048189* 17048189 | ||
196. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr 2009; 28 (2): 131-41 | *19828898* 19828898 | ||
197. N-acetylcysteine partially reverses oxidative stress and apoptosis exacerbated by Mg-deficiency culturing conditions in primary cultures of rat and human hepatocytes. | *17031004* 17031004 | ||
198. Hypomagnesemia in critically ill medical patients. | *21751660* 21751660 | ||
199. Magnesium affects the cytokine secretion of CD4(+) T lymphocytes in acute asthma. | *23134345* 23134345 | ||
200. Fusion of mouse alveolar macrophages induced by 1 alpha,25-dihydroxyvitamin D3 involves extracellular, but not intracellular, calcium. | *2105966* 2105966 | ||
201. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. | *21602712* 21602712 | ||
202. Macrophage migration inhibition factor: interactions with calcium, magnesium, and cyclic AMP. | *212481* 212481 | ||
203. Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. | *19540598* 19540598 | ||
204. Diversity of DNA-hydrolyzing antibodies from the sera of autoimmune-prone MRL/MpJ-lpr mice. | *20842640* 20842640 | ||
205. Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs. | *22714899* 22714899 | ||
206. Magnesium deficiency results in an increased formation of osteoclasts. | *23517915* 23517915 | ||
207. Magnesium sulfate suppresses inflammatory responses by human umbilical vein endothelial cells (HuVECs) through the NFkappaB pathway. | *16952401* 16952401 | ||
208. Mechanisms of action of neuroprotectants in stroke. | *17895214* 17895214 | ||
209. Magnesium sulfate inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated RAW264.7 macrophages in vitro. | *22487382* 22487382 | ||
210. Magnesium deficiency promotes secretion of high-mobility group box 1 protein from lipopolysaccharide-activated macrophages in vitro. | *22608546* 22608546 | ||
211. Magnesium sulfate mitigates acute lung injury in endotoxemia rats. | *21610432* 21610432 | ||
212. Measurement of ionized magnesium in whole blood, plasma and serum with a new ion-selective electrode in healthy and diseased human subjects. | *1844565* 1844565 | ||
213. Relation of magnesium to osteoporosis and calcium urolithiasis. | *1844560* 1844560 | ||
214. The role of magnesium in lung diseases: asthma, allergy and pulmonary hypertension. | *1844555* 1844555 | ||
215. Cardiovascular risk factors and magnesium: relationships to atherosclerosis, ischemic heart disease and hypertension. | *1844551* 1844551 | ||
216. Hypothesis for risk of death or serious sequela from asthmatic use of magnesium throat lozenges due to 8- to 310-fold rhinovirus release increase by concentrated magnesium. | *19713049* 19713049 | ||
217. Impaired calcium uptake by cardiac sarcoplasmic reticulum and its underlying mechanism in endotoxin shock. | *1770948* 1770948 | ||
218. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. | *21135566* 21135566 | ||
219. Suboptimal magnesium status in the United States: are the health consequences underestimated? | *22364157* 22364157 | ||
220. Magnesium transport in hypertension. | *18029156* 18029156 | ||
221. Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study. | *21929603* 21929603 | ||
222. Nutritional status and complications in children with diabetic ketoacidosis. | *22610448* 22610448 | ||
223. Magnesium sulfate reduces bacterial LPS-induced inflammation at the maternal-fetal interface. | *22341339* 22341339 | ||
224. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections. | *20067167* 20067167 | ||
225. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. | *20934153* 20934153 | ||
226. The role of magnesium in edema and blood brain barrier disruption | *29920006* 29920006 | ||
PMC6629001 227. TRPM7 channel inhibition exacerbates pulmonary arterial hypertension through MEK/ERK pathway. | *31219801* 31219801 | ||
228. Magnesium improves cisplatin-mediated tumor killing while protecting against cisplatin-induced nephrotoxicity. | *28424213* 28424213 | ||
PMC6203428 229. Multimodal General Anesthesia: Theory and Practice. | *30252709* 30252709 | ||
PMC5956596 230. Pseudogout - a rare manifestation of hungry bone syndrome after focused parathyroidectomy. | *29607728* 29607728 | ||
231. Magnesium augments immunosuppressive effects of a corticosteroid in obese mice with airway inflammation. | *31175714* 31175714 | ||
PMC6163591 232. The Role of Calcium in Inflammation-Associated Bone Resorption. | *30071694* 30071694 | ||
PMC5372215 233. Near death by milk of magnesia. | *28325719* 28325719 | ||
PMC5406298 234. Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanism. | *28198010* 28198010 | ||
PMC3730411 235. Mechanisms underlying cell death in ischemia-like damage to the rat spinal cord in vitro. | *23828570* 23828570 | ||
236. Magnesium sulfate attenuates lipopolysaccharides-induced acute lung injury in mice. | *31670284* 31670284 | ||
PMC4557387 237. Neutrophil extracellular traps can activate alternative complement pathways. | *25963026* 25963026 | ||
PMC5098019 238. Small-Volume Adenosine, Lidocaine, and Mg2+ 4-Hour Infusion Leads to 88% Survival after 6 Days of Experimental Sepsis in the Rat without Antibiotics. | *27581435* 27581435 | ||
PMC4301798 239. Adenosine, lidocaine and Mg2+ improves cardiac and pulmonary function, induces reversible hypotension and exerts anti-inflammatory effects in an endotoxemic porcine model. | *25497775* 25497775 | ||
240. Extracellular Mg concentration and Ca blockers modulate the initial steps of the response of Th2 lymphocytes in co-culture with macrophages and dendritic cells. | *26083578* 26083578 | ||
241. Magnesium sulphate in the Emergency Department: an old, new friend. | *31115035* 31115035 | ||
PMC4550379 242. Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. | *26060214* 26060214 | ||
PMC5988891 243. Magnesium Ions Inhibit the Expression of Tumor Necrosis Factor alpha and the Activity of gamma-Secretase in a beta-Amyloid Protein-Dependent Mechanism in APP/PS1 Transgenic Mice. | *29899688* 29899688 | ||
PMC5143678 244. Magnesium Sulfate Prevents Placental Ischemia-Induced Increases in Brain Water Content and Cerebrospinal Fluid Cytokines in Pregnant Rats. | *28008305* 28008305 | ||
PMC3832323 245. Magnesium deficiency upregulates sphingomyelinases in cardiovascular tissues and cells: cross-talk among proto-oncogenes, Mg(2+), NF-kappaB and ceramide and their potential relationships to resistant hypertension, atherogenesis and cardiac failure. | *24260592* 24260592 | ||
PMC5926493 246. Magnesium and Human Health: Perspectives and Research Directions. | *29849626* 29849626 | ||
PMC6770589 247. Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats. | *31540416* 31540416 | ||
PMC6358963 248. Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D(3). | *30658432* 30658432 | ||
PMC5877525 249. Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials. | *29495444* 29495444 | ||
PMC6055085 250. The role of PPAR-gamma and NFKB genes expression in muscle to improve hyperglycemia in STZ-induced diabetic rat following magnesium sulfate administration. | *30042813* 30042813 | ||
PMC6417243 251. Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. | *30866950* 30866950 | ||
PMC6144272 252. Stat3 inhibitor abrogates the expression of PD-1 ligands on lymphoma cell lines. | *28496056* 28496056 | ||
PMC4625810 253. Hypomagnesemia in Critically Ill Sepsis Patients. | *26566403* 26566403 | ||
PMC5061963 254. Sweet Bones: The Pathogenesis of Bone Alteration in Diabetes. | *27777961* 27777961 | ||
PMC5783146 255. Magnesium deficiency and increased inflammation: current perspectives. | *29403302* 29403302 | ||
PMC3726845 256. Magnesium: a versatile drug for anesthesiologists. | *23904932* 23904932 | ||
PMC6330805 257. Serum magnesium levels and its correlation with level of control in patients with asthma: A hospital-based, cross-sectional, prospective study. | *30604720* 30604720 | ||
PMC6120318 258. Serum magnesium levels and its correlation with level of control in patients with asthma: A hospital-based, cross-sectional, prospective study. | *30168460* 30168460 | ||
259. Extracellular magnesium and calcium blockers modulate macrophage activity. | *27160489* 27160489 | ||
260. Influence of extracellular magnesium on phagocytosis and free cytosolic Mg levels in differentiated U937 and MH-S cells. | *25967881* 25967881 | ||
261. TRPM7 involvement in cancer: a potential prognostic factor. | *25367030* 25367030 | ||
262. Potential interplay between NFkappaB and PPARgamma in human dermal microvascular endothelial cells cultured in low magnesium. | *25245457* 25245457 | ||
PMC4418123 263. Relationship between Intracellular Magnesium Level, Lung Function, and Level of Asthma Control in Children with Chronic Bronchial Asthma. | *25977631* 25977631 | ||
PMC6323247 264. Magnesium sulfate ameliorates carbon monoxideinduced cerebral injury in male rats. | *30569139* 30569139 | ||
PMC6461616 265. Immunoregulation of macrophages by dynamic ligand presentation via ligand-cation coordination. | *30979900* 30979900 | ||
PMC6379356 266. The role of oral magnesium supplements for the management of stable bronchial asthma: a systematic review and meta-analysis. | *30778086* 30778086 | ||
PMC5516748 267. The Involvement of Mg(2+) in Regulation of Cellular and Mitochondrial Functions. | *28757913* 28757913 | ||
PMC7035964 268. Magnesium sulfate inhibits inflammation through P2X7 receptors in human umbilical vein endothelial cells. | *31493768* 31493768 | ||
269. Magnesium in man: implications for health and disease. | *25540137* 25540137 | ||
PMC5690633 270. Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. | *29145467* 29145467 | ||
PMC4167554 271. A magnesium based phosphate binder reduces vascular calcification without affecting bone in chronic renal failure rats. | *25229549* 25229549 | ||
PMC5080508 272. Serum Magnesium and Vitamin D Levels as Indicators of Asthma Severity. | *27818797* 27818797 | ||
PMC4251077 273. Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study. | *25485151* 25485151 | ||
PMC5772083 274. Magnesium sulfate protects the heart against carbon monoxide-induced cardiotoxicity in rats. | *29387113* 29387113 | ||
275. Medication Regimens for Managing Acute Asthma. | *29794211* 29794211 | ||
PMC5794996 276. Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation. | *29391410* 29391410 | ||
PMC5309879 277. In vitro and in vivo responses of macrophages to magnesium-doped titanium. | *28198427* 28198427 | ||
PMC4101474 278. Inactivation of TRPM7 kinase activity does not impair its channel function in mice. | *25030553* 25030553 | ||
279. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. | *23698380* 23698380 | ||
PMC6378568 280. Three cases of transient neonatal pseudohypoparathyroidism. | *30799898* 30799898 | ||
PMC4127587 281. Domino effect of hypomagnesemia on the innate immunity of Crohn's disease patients. | *25126398* 25126398 | ||
282. High-Purity Magnesium Staples Suppress Inflammatory Response in Rectal Anastomoses. | *28240546* 28240546 | ||
283. Magnesium (Mg) based interference screws developed for promoting tendon graft incorporation in bone tunnel in rabbits. | *28919510* 28919510 | ||
284. Effects of extracellular magnesium on the differentiation and function of human osteoclasts. | *24531013* 24531013 | ||
285. Hypomagnesemia and hypermagnesemia. | *30220246* 30220246 | ||
286. Impairment of reticuloendothelial system function with sepsis and its improvement with ATP-MgCl2 plus glucose administration. | *262800* 262800 | ||
287. Calcium oxalate in sarcoid granulomas. With particular reference to the small ovoid body and a note on the finding of dolomite. | *3177273* 3177273 | ||
288. Fatal Hypermagnesemia Due to Laxative Use. | *29661354* 29661354 | ||
289. Maternal magnesium sulfate fetal neuroprotective effects to the fetus: inhibition of neuronal nitric oxide synthase and nuclear factor kappa-light-chain-enhancer of activated B cells activation in a rodent model. | *27018467* 27018467 | ||
290. Antigen-independent binding of T-cells by dendritic cells and alveolar macrophages in the rat. | *2492172* 2492172 | ||
291. Pharmacologic modulation of spontaneous histamine release. | *2472760* 2472760 | ||
292. Fluid and electrolyte considerations in diuretic therapy for hypertensive patients with chronic obstructive pulmonary disease. | *2867747* 2867747 | ||
293. Phosphatase of regenerating liver maintains cellular magnesium homeostasis. | *29487165* 29487165 | ||
294. Improved osteogenesis and angiogenesis of magnesium-doped calcium phosphate cement via macrophage immunomodulation. | *27709132* 27709132 | ||
295. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-kappaB and NFATc1 signaling. | *24816285* 24816285 | ||
296. Esomeprazole ameliorates CCl4 induced liver fibrosis in rats via modulating oxidative stress, inflammatory, fibrogenic and apoptotic markers. | *29156525* 29156525 | ||
297. Activation of NF-kappaB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKbeta expression. | *23784082* 23784082 | ||
298. High magnesium prevents matrix vesicle-mediated mineralization in human bone marrow-derived mesenchymal stem cells via mitochondrial pathway and autophagy. | *29024399* 29024399 | ||
299. Divalent metal requirement for soluble immune response suppressor (SIRS) activity. | *2521303* 2521303 | ||
300. Mpn491, a secreted nuclease of Mycoplasma pneumoniae, plays a critical role in evading killing by neutrophil extracellular traps. | *27603754* 27603754 | ||
301. Attenuation of Magnesium Sulfate on CoCl(2)-Induced Cell Death by Activating ERK1/2/MAPK and Inhibiting HIF-1alpha via Mitochondrial Apoptotic Signaling Suppression in a Neuronal Cell Line. | *26211648* 26211648 | ||
302. Hypophosphatemia as a prognostic value in acute exacerbation of COPD. | *23659185* 23659185 | ||
303. Protective Effects of Magnesium Sulfate on Radiation Induced Brain Injury in Rats. | *29366417* 29366417 | ||
304. Mg2+ homeostasis: the balancing act of TRPM6. | *24906182* 24906182 | ||
305. Comparative study of antifibrotic activity of some magnesium-containing supplements on experimental liver toxicity. Molecular study. | *27151930* 27151930 | ||
306. Management of acute asthma in the emergency department. | *24040898* 24040898 | ||
307. Clinical pharmacokinetics of magnesium sulfate in the treatment of children with severe acute asthma. | *27909740* 27909740 | ||
308. Effects of magnesium deficiency--more than skin deep. | *24928863* 24928863 | ||
309. Vascular sphingolipids in physiological and pathological adaptation. | *27100498* 27100498 | ||
310. Immune-inflammatory activation after a single laparotomy in a rat model: effect of adenosine, lidocaine and Mg(2+) infusion to dampen the stress response. | *28691873* 28691873 | ||
311. Effect of magnesium deficiency on interleukin production by Fisher rats: effect of interleukins on reduced in vitro lymphocyte responses to concanavalin A and lipopolysaccharide. | *2788143* 2788143 | ||
312. The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. | *28218351* 28218351 | ||
313. Up-Regulation of Transient Receptor Potential Melastatin 6 Channel Expression by Tumor Necrosis Factor-alpha in the Presence of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor. | *27925186* 27925186 | ||
314. Severe enterovirus 68 respiratory illness in children requiring intensive care management. | *26305825* 26305825 | ||
315. Regulatory responses of hepatocytes, macrophages and vascular endothelial cells to magnesium deficiency. | *29454997* 29454997 | ||
316. Neutrophil extracellular traps promote differentiation and function of fibroblasts. | *24740698* 24740698 | ||
317. The spectrum of onset of acute kidney injury in premature infants less than 30 weeks gestation. | *26796125* 26796125 | ||
318. Effects of MgSO4 on inhibiting Nod-like receptor protein 3 inflammasome involve decreasing intracellular calcium. | *29229137* 29229137 | ||
319. Phosphoinositide 3-kinase beta, phosphoinositide 3-kinase delta, and phosphoinositide 3-kinase gamma mediate the anti-inflammatory effects of magnesium sulfate. | *25972311* 25972311 | ||
320. Magnesium sulfate provides neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-kappaB pathway. | *23628437* 23628437 | ||
321. Phosphoinositide 3-kinase/Akt pathway is involved in mediating the anti-inflammation effects of magnesium sulfate. | *23859135* 23859135 | ||
322. 3% NaCl adenosine, lidocaine, Mg2+ (ALM) bolus and 4 hours "drip" infusion reduces noncompressible hemorrhage by 60% in a rat model. | *28520687* 28520687 | ||
323. Adenosine, lidocaine, and Mg2+ (ALM): From cardiac surgery to combat casualty care--Teaching old drugs new tricks. | *26683400* 26683400 | ||
324. Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis. | *25807406* 25807406 | ||
325. Adenosine, lidocaine and Mg2+ (ALM) induces a reversible hypotensive state, reduces lung edema and prevents coagulopathy in the rat model of polymicrobial sepsis. | *25159253* 25159253 | ||
326. Dietary magnesium supplementation prevents and reverses vascular and soft tissue calcifications in uremic rats. | *28760336* 28760336 | ||
327. Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease. | *26061542* 26061542 | ||
328. A case of iatrogenic acute hypermagnesemia mimicking sepsis. | *27467105* 27467105 | ||
329. Ca2+/Mg2+ homeostasisrelated TRPM7 channel mediates chondrocyte hypertrophy via regulation of the PI3KAkt signaling pathway. | *28849029* 28849029 | ||
330. Clinical Course of Enterovirus D68 in Hospitalized Children. | *28187115* 28187115 | ||
331. Pretreatment with magnesium ameliorates lipopolysaccharide-induced liver injury in mice. | *26398385* 26398385 | ||
332. The molecular biology and pathophysiology of vascular calcification. | *24685968* 24685968 | ||
333. Admission hypomagnesemia linked to septic shock in patients with systemic inflammatory response syndrome. | *26335852* 26335852 | ||
334. The Effects of Magnesium Sulfate on the Inflammatory Response of Placentas Perfused With Lipopolysaccharide: Using the Ex Vivo Dual-Perfused Human Single-Cotyledon Model. | *29113582* 29113582 | ||
335. Magnesium and the pathogenesis of toxic shock syndrome. Rev Infect Dis 1989; 11 Suppl 1 (ä): S167-73; discussion S173-5 | *2928633* 2928633 | ||
336. Effect of trace metals on the synthesis of toxic shock syndrome toxin 1. Rev Infect Dis 1989; 11 Suppl 1 (ä): S145-49; discussion S149-50 | *2928630* 2928630 | ||
337. Does Hypomagnesemia Impact on the Outcome of Patients Admitted to the Intensive Care Unit? A Systematic Review and Meta-Analysis. | *27753792* 27753792 | ||
338. Pharmacologic Management of Subarachnoid Hemorrhage. | *25701766* 25701766 | ||
339. Magnesium attenuates the neutrophil respiratory burst in adult asthmatic patients. | *8959161* 8959161 | ||
PMC1061115 340. Effects of magnesium sulphate and nitric oxide in pulmonary hypertension induced by hypoxia in newborn piglets. | *7820707* 7820707 | ||
PMC1667821 341. Effect of divalent cations on lysosomal enzyme release from macrophages [proceedings]. | *338078* 338078 | ||
342. Investigation of the effect of short-term change in dietary magnesium intake in asthma. | *9387944* 9387944 | ||
343. The role of Mg2+ and Ca2+ in the direct macrophage-mediated tumor cell lysis. | *6797841* 6797841 | ||
344. The role of divalent cations in antibody-dependent macrophage-mediated tumor lysis. | *6771163* 6771163 | ||
PMC6902094 345. A Biodegradable Mg-Based Alloy Inhibited the Inflammatory Response of THP-1 Cell-Derived Macrophages Through the TRPM7-PI3K-AKT1 Signaling Axis. | *31849975* 31849975 | ||
346. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. | *9556624* 9556624 | ||
347. Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. | *9506997* 9506997 | ||
348. Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. | *9202042* 9202042 | ||
349. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. | *9133673* 9133673 | ||
PMC2191369 350. Separate metabolic pathways leading to DNA fragmentation and apoptotic chromatin condensation. | *8294867* 8294867 | ||
PMC1295297 351. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. | *7562826* 7562826 | ||
352. Multiple complications in severe diabetic ketoacidosis. A short review of the literature. | *821284* 821284 | ||
353. Mechanisms of Vascular Calcification in Kidney Disease. | *31831120* 31831120 | ||
354. Magnesium and its therapeutic uses: a review. | *8304365* 8304365 | ||
355. Risk of magnesium for respiratory failure in pregnancy. | *9731870* 9731870 | ||
356. PI3K Catalytic Subunits alpha and beta Modulate Cell Death and IL-6 Secretion Induced by Talc Particles in Human Lung Carcinoma Cells. | *31513749* 31513749 | ||
357. The assessment and management of adults with status asthmaticus. | *7735578* 7735578 | ||
358. Mononuclear blood cell magnesium in older subjects: evaluation of its use in clinical practice. | *8434863* 8434863 | ||
359. Inflammation-induced remote superactivity of macrophages. | *3729296* 3729296 | ||
360. Pharmacologic Therapies in Patients With Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analysis. | *32092762* 32092762 | ||
361. Magnesium fortification of water. A possible step forward in preventive medicine? | *9538378* 9538378 | ||
362. The relation between magnesium, blood histamine level and eosinophilia in the acute stage of the allergic reactions in humans. | *749826* 749826 | ||
363. Magnesium deficiency in bacteremic patients. | *3337602* 3337602 | ||
364. The relationship of biochemical and histometric determinants of uremic bone. | *582255* 582255 | ||
365. Pretreatment of simvastatin on liver trace element levels during endotoxemia. | *30450988* 30450988 | ||
366. The effect of some drugs on oxalic acid excretion in urine. | *4392557* 4392557 | ||
367. Protein phosphatase magnesium-dependent 1A induces inflammation in rheumatoid arthritis. | *31791585* 31791585 | ||
368. Activation of Dusp14 protects against osteoclast generation and bone loss by regulating AMPKalpha-dependent manner. | *31526569* 31526569 | ||
369. NIPA2 regulates osteoblast function via its effect on apoptosis pathways in type 2 diabetes osteoporosis. | *31003774* 31003774 | ||
370. Electrophysiology of phagocytic membranes. Role of divalent cations in membrane hyperpolarizations of macrophage polykaryons. | *3955048* 3955048 | ||
371. The Impact of Trace Minerals on Bone Metabolism. | *30467628* 30467628 | ||
372. Magnesium and vitamin C supplementation attenuates steroid-associated osteonecrosis in a rat model. | *32045781* 32045781 | ||
373. The role of apoptosis (programmed cell death) in haemopoiesis and the immune system. | *8467234* 8467234 | ||
374. Hypophosphataemia and hypokalaemia in patients with hypomagnesaemia. | *7841832* 7841832 | ||
375. Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat model. | *9389906* 9389906 | ||
376. Immunoregulatory properties of some heavy metals in physiology and pathology conditions. Part I. | *3915874* 3915874 | ||
377. Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation. | *3124941* 3124941 | ||
378. Influence of magnesium supplementation on bone turnover in the normal young mouse. | *6652550* 6652550 | ||
379. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. | *31250885* 31250885 | ||
380. Magnesium protects against sepsis by blocking gasdermin D N-terminal-induced pyroptosis. | *31209359* 31209359 | ||
381. The role of divalent cations in interactions between lymphokines and macrophages. | *6773670* 6773670 | ||
382. The mechanism of action of soluble lymphocytic mediators. II. Modification of macrophage migration and migration inhibitory factor action by drugs, enzymes and cationic environment. | *4376058* 4376058 | ||
383. Bronchial reactivity and intracellular magnesium: a possible mechanism for the bronchodilating effects of magnesium in asthma. | *9680494* 9680494 | ||
384. Reduced inflammatory response by incorporating magnesium into porous TiO2 coating on titanium substrate. | *30041151* 30041151 | ||
385. NLRP3 Inflammasome Activation Leads to Epileptic Neuronal Apoptosis. | *30468127* 30468127 | ||
386. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. | *3956882* 3956882 | ||
387. Systemic drugs with impact on osteoarthritis. | *31726891* 31726891 | ||
388. Effect of magnesium supplementation on lactate clearance in critically ill patients with severe sepsis: a randomized clinical trial. | *31814044* 31814044 | ||
389. Prospective study of serum and ionized magnesium pharmacokinetics in the treatment of children with severe acute asthma. | *30259065* 30259065 | ||
390. Extracellular and intracellular magnesium concentrations in asthmatic patients. | *8224127* 8224127 | ||
391. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. | *30501441* 30501441 | ||
392. Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. | *7338480* 7338480 | ||
393. Chromatin changes in apoptosis. | *6975767* 6975767 | ||
394. Lymphokine-induced macrophage aggregation: studies on the involvement of Mg2+. | *6806210* 6806210 | ||
395. The role of magnesium in different inflammatory diseases. | *31172335* 31172335 | ||
396. Magnesium sulfate inhibits binding of lipopolysaccharide to THP-1 cells by reducing expression of cluster of differentiation 14. | *30721372* 30721372 | ||
397. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism. | *31264087* 31264087 | ||
398. Blood mononuclear cell magnesium in normal pregnancy and preeclampsia. | *3584731* 3584731 | ||
399. Role of magnesium in regulation of lung function. | *8509592* 8509592 | ||
400. Magnesium attenuates pulmonary hypertension due to hypoxia and group B streptococci. | *8002524* 8002524 | ||
401. Magnesium protects against anaphylactic shock and cardiac myolysis in guinea-pigs. | *8736070* 8736070 | ||
402. Magnesium alginate in children with uncontrolled asthma. | *30945510* 30945510 | ||
403. The calcium-buffering phase of bone mineral: some clues to its form and formation. | *3455165* 3455165 | ||
404. Cell-cycle arrest, micronucleus formation, and cell death in growth inhibition of MCF-7 breast cancer cells by tamoxifen and cisplatin. | *8879258* 8879258 | ||
405. Magnesium protects mouse hippocampal HT22 cells against hypoxia-induced injury by upregulation of miR-221. | *31512791* 31512791 | ||
406. High concentration magnesium inhibits extracellular matrix calcification and protects articular cartilage via Erk/autophagy pathway. | *31161622* 31161622 | ||
407. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function. | *6822651* 6822651 | ||
408. Serum magnesium and digitalis toxicity in chronic obstructive lung disease. | *521652* 521652 | ||
409. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. | *6450254* 6450254 | ||
410. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management. | *29914278* 29914278 | ||
411. Fetal neuroprotective mechanism of maternal magnesium sulfate for late gestation inflammation: in a rodent model. | *30835601* 30835601 | ||
412. Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. | *31825817* 31825817 | ||
413. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. | *6422024* 6422024 | ||
414. Comparison of the Severity of Respiratory Disease in Children Testing Positive for Enterovirus D68 and Human Rhinovirus. | *29655864* 29655864 | ||
415. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. | *8231165* 8231165 | ||
416. Effect of adenosine triphosphate-glucose administration following sepsis. | *7412271* 7412271 | ||
417. Adenosine, lidocaine, and Mg2+ fluid therapy leads to 72-hour survival after hemorrhagic shock: A model for studying differential gene expression and extending biological time. | *31162330* 31162330 | ||
418. Adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid protects against experimental traumatic brain injury. | *29554045* 29554045 | ||
419. Magnesium prevents vascular calcification in Klotho deficiency. | *31866113* 31866113 | ||
420. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. | *7914305* 7914305 | ||
421. Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats. | *29940240* 29940240 | ||
422. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. | *9820125* 9820125 | ||
423. Magnesium deficiency heightens lipopolysaccharide-induced inflammation and enhances monocyte adhesion in human umbilical vein endothelial cells. | *30398154* 30398154 | ||
424. Varying magnesium concentration elicits changes in inflammatory response in human umbilical vein endothelial cells (HUVECs). | *30530425* 30530425 | ||
425. Early morphological and immunological alterations in the spleen during magnesium deficiency in the rat. | *9800684* 9800684 | ||
426. Triglyceride-rich lipoproteins from magnesium-deficient rats are more susceptible to oxidation by cells and promote proliferation of cultured vascular smooth muscle cells. | *7547176* 7547176 | ||
427. Commentary on recent clinical advances: magnesium depletion, magnesium deficiency and asthma. | *8861139* 8861139 | ||
428. Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. | *8861137* 8861137 | ||
429. Magnesium, Staphylococcus aureus and toxic shock syndrome. | *3075248* 3075248 | ||
430. Magnesium and immune function: an overview. | *3075245* 3075245 | ||
431. Phagocytes and monokines: perspectives on metabolic regulation in sepsis. | *3075244* 3075244 | ||
432. Magnesium and the lungs. | *3072451* 3072451 | ||
433. Glucose loading induces DNA fragmentation in rat proximal tubular cells. | *8931638* 8931638 | ||
434. Magnesium deficiency induces bone loss in the rat. | *9705567* 9705567 | ||
435. The physicochemical structure of bone: cellular and noncellular elements. | *8202055* 8202055 | ||
436. Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patients. | *3211092* 3211092 | ||
437. Physiologic and pharmacologic regulation of bone resorption. | *4314044* 4314044 | ||
438. Biochemical and morphological aspects of bone tissue in chronic renal failure. | *4842689* 4842689 | ||
439. Down-Regulated Expression of Magnesium Transporter Genes Following a High Magnesium Diet Attenuates Sciatic Nerve Crush Injury. | *29672725* 29672725 | ||
440. Endocrine manifestations of critical illness in the child. | *3543820* 3543820 | ||
441. Safety and efficacy of magnesium sulfate infusions in children with status asthmaticus. | *7937295* 7937295 | ||
442. Effects of ATP-magnesium chloride on the cardiopulmonary manifestations of group B streptococcal sepsis in the piglet. | *8848333* 8848333 | ||
443. Deregulated renal magnesium transport during lipopolysaccharide-induced acute kidney injury in mice. | *30726531* 30726531 | ||
444. The influence of CSF calcium and magnesium on the ventilatory response to carbon dioxide during hyperoxia. | *988552* 988552 | ||
445. On the pathogenesis of toxic shock syndrome. | *3317745* 3317745 | ||
446. Intravenous theophylline-induced excretion of calcium, magnesium and sodium in patients with recurrent asthmatic attacks. | *8197398* 8197398 | ||
447. Evaluation of magnesium status in Crohn's disease as assessed by intracellular analysis and intravenous magnesium infusion. | *3399827* 3399827 | ||
448. Role of magnesium ion in the pathogenesis of toxic shock syndrome. | *3137706* 3137706 | ||